A case of pegylated interferon alpha-related diabetic ketoacidosis: Can this complication be avoided?

Acta Diabetologica

Volumn 44, Issue 3, 2007, Pages 167-169

  Tosone, G ^a   Borgia, G ^a   Gentile, I ^a   Cerini, R ^a   Conte, M C D ^a   Orlando, R ^a   Piazza, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Chronic hepatitis C; Ketoacidosis; PEG IFN; Type 1 diabetes mellitus

Indexed keywords

INSULIN; ISOPHANE INSULIN; PEGINTERFERON; RIBAVIRIN;

ADULT; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; BODY MASS; CASE REPORT; CLINICAL FEATURE; DIABETIC KETOACIDOSIS; DRUG MEGADOSE; FEMALE; HEPATITIS C; HOSPITALIZATION; HUMAN; IMMUNOFLUORESCENCE; INSULIN TREATMENT; LOW DRUG DOSE; PRIORITY JOURNAL;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-BETA; RNA, VIRAL; VIRAL LOAD;

EID: 34548165221     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-007-0259-1     Document Type: Article

References (10)

1. Recasens M, Aguilera E, Ampurdanes S, Sanchez Tapias JM, Simo O, Casamitjana R, Conget I (2001) Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C. Diabet Med 18:764-767
2. Fabris P, Floreani A, Tositti G, Vergani D, De Lalla F, Betterle C (2003) Review article: type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Aliment Pharmacol Ther 18:549-558
3. Bosi E, Minelli R, Bazzigaluppi E, Salvi M (2001) Fulminant autoimmune type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease? Diabet Med 18:329-332
4. Uto H, Matsuoka H, Murata M, Okamoto, T, Miyata Y, Hori T, Ido A, Hirono S, Hayashi K, Tsubouchi H (2000) A case of chronic hepatitis C developing insulin-dependent diabetes mellitus associated with various autoantibodies during interferon therapy. Diabetes Res Clin Pract 49:101-106
5. Konrad T, Zeuzem S, Vicini P, Toffolo G, Briem D, Lormann J, Hermann G, Berger A, Kusterer K, Teuber G, Cobelli C, Usadel KH (2000) Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon α. Eur J Clin Invest 30:111-121
6. Primo Vera J (2004) Pegylated-interferon-induced diabetes mellitus type 1 in two patients with chronic hepatitis C. Gastroenterol Hepatol 27:69
7. Jabr FI, Ordinario MM (2003) Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy. Am J Med 115:148-159
8. Chen L-K, Chou Y-C, Tsait S-T, Hwang S-J, Lee S-D (2005) Hepatitis C virus infection-related type 1 diabetes mellitus. Diabet Med 22:340-343
9. Schories M, Peters T, Rasenack J, Reincke M (2004) Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha. Dtsch Med Wochenschr 129:1120-1124
10. Tohda G, Oida K, Higashi S, Hayashi T, Miyamori I (1998) Interferon alfa and development of type 1 diabetes: a case without insulin resistance. Diabetes Care 21:1774